According to the Federal Trade Commission, UnitedHealth Group has been charging patients markups on lifesaving drugs. Between 2017 and 2022, UnitedHealth Group’s Optum, Cigna’s Express Scripts and CVS Health’s CVS Caremark marked up their prices by hundreds — and in some cases,

A new Federal Trade Commission (FTC) report found that the three largest Pharmacy Benefit Managers (PBMs) have taken in large profits on lifesaving medicine for heart disease, cancer and HIV. Pharmacy Benefit Managers are third-party companies connected to pharmacies that are intermediaries between insurance providers and pharmaceutical manufacturers and claim to reduce consumer costs.

From 2017 to 2022, the companies marked up prices at their pharmacies by hundreds or thousands of percent, netting them $7.3 billion in revenue.

FTC stated that the 'Big 3' PBM organisations collectively generated over £5.94 billion ($7.3 billion) in revenue from 2017 to 2022.

UnitedHealth Group says the impact from the cyberattack last year at its Change Healthcare subsidiary is much wider than previously understood, affecting

FTC: ‘Big 3’ Pharmacy Benefit Managers Engaged in Price Gouging, PBMs, UnitedHealth OptumRx, CVS Caremark Rx, Express Scripts

UnitedHealth reported fourth-quarter results on Thursday that reflected persistent challenges for the health insurance sector.

Regulators published their most detailed findings yet on how some of the nation’s largest companies profited from ‘excess’ prescription price hikes of 1,000% or more.

UnitedHealth Group posted mixed Q4 results, with EPS beating estimates and revenue falling short. The company reaffirmed its 2025 guidance.

As the year begins under a new Trump Administration, healthcare providers and private equity firms should consider the antitrust

The ransomware attack last year against UnitedHealth Group subsidiary Change Healthcare exposed data of more than 190 million people — up from previous reports of 100 million — according to multiple outlets Jan.

The share of in-network federal health insurance exchange plan claims denied in 2023 was the highest since 2015, according to a KFF analysis.